Trinity Biotech Plc (TRIB)
1.07
-0.21
(-16.41%)
USD |
NASDAQ |
Dec 24, 12:59
1.01
-0.06
(-5.61%)
After-Hours: 13:59
Trinity Biotech SG&A Expense (TTM): 24.41M for June 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amarin Corp. Plc | 121.28M |
| DBV Technologies SA | 28.71M |
| Ascendis Pharma A/S | 446.44M |
| Cellectis SA | 19.93M |
| Akari Therapeutics Plc | 10.20M |